Citizens Business Bank’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,750
Closed -$2.03M 292
2017
Q3
$2.03M Buy
2,750
+550
+25% +$457K 0.34% 71
2017
Q2
$1.91M Hold
2,200
0.32% 78
2017
Q1
$1.87M Hold
2,200
0.31% 80
2016
Q4
$1.68M Sell
2,200
-100
-4% -$75.6K 0.3% 85
2016
Q3
$1.89M Sell
2,300
-400
-15% -$346K 0.35% 76
2016
Q2
$2.25M Buy
2,700
+1,100
+69% +$919K 0.42% 68
2016
Q1
$1.47M Hold
1,600
0.28% 97
2015
Q4
$1.65M Sell
1,600
-1,050
-40% -$1.05M 0.32% 87
2015
Q3
$2.5M Hold
2,650
0.47% 68
2015
Q2
$2.77M Buy
+2,650
New +$2.77M 0.48% 72

Other funds holding AGN.PRA

Citizens Business Bank's AGN.PRA Position: Q4 2017 in Review

Citizens Business Bank sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 2,750 shares — an estimated $2.03M sold.

Citizens Business Bank first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $2.77M in Q2 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Citizens Business Bank reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Citizens Business Bank sold 2,750 Allergan plc shares in Q4 2017, an estimated $2.03M.
  • Citizens Business Bank first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Citizens Business Bank's Allergan plc position peaked at $2.77M in Q2 2015.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Citizens Business Bank's 13F filing for Q4 2017, filed 18 Nov 2022.